Skip to main content
Top
Published in: BMC Geriatrics 1/2017

Open Access 01-12-2017 | Research article

Olfactory testing in consecutive patients referred with suspected dementia

Authors: Ib Thrane Christensen, Elna-Marie Larsson, Ida E. Holm, Ole B.F. Nielsen, Stig Andersen

Published in: BMC Geriatrics | Issue 1/2017

Login to get access

Abstract

Background

Alzheimer’s disease (AD) is the most common cause of dementia and early and accurate diagnosis is important. Olfactory dysfunction is an early sign of AD. The contribution by test of olfactory function has been surveyed in AD vs a line of conditions but remains to be settled in the workup of unselected patients referred with suspected dementia.

Methods

We performed a two-step investigation: first, a comparative study of healthy controls and probable AD patients to test the applicability of the chosen scents (cuisine study); second, a study of consecutive patients referred to our geriatric outpatient clinic for suspected dementia with the investigating personnel blinded to the results of the Olfactory Test (blinded study).

Results

The sum of scents detected discriminated patients with probable AD from controls in the cuisine study (n = 40; p < 0.001; area under ROC curve 0.94). In the blinded study (n = 50) the diagnosis was probable AD in 48%, minimal cognitive impairment in 24%, vascular dementia in 8%, alcohol induced impairment in 12%, depression in 4%, and Parkinson’s disease and Lewy body dementia in 2%. Area under the ROC-curve was 0.67. The odds ratio for probable AD with 2+ smell errors was 12 (95%-CI: 1.3–101; p = 0.026 (reference 0–1 smell errors)) age adjusted. None in the AD group had zero smell errors (Negative Predictive Value 100%).

Conclusion

Olfactory testing may support to dismiss the diagnosis of probable AD in the workup of a mixed group of patients referred with cognitive impairment. Still, it had a low sensitivity for probable AD.
Literature
1.
go back to reference Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’ disease. Lancet. 2011;377:1019–31.CrossRefPubMed Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’ disease. Lancet. 2011;377:1019–31.CrossRefPubMed
2.
go back to reference Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA. Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J Geriatr Psychiatry Neurol. 2005;18:218–23.CrossRefPubMedPubMedCentral Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA. Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J Geriatr Psychiatry Neurol. 2005;18:218–23.CrossRefPubMedPubMedCentral
3.
go back to reference Chen L, Reed C, Happich M, Nyhuis A, Lenox-Smith A. Health care resource utilisation in primary care prior to and after a diagnosis of Alzheimer’s disease: a retrospective, matched case-control study in the United Kingdom. BMC Geriatr. 2014;14:76.CrossRefPubMedPubMedCentral Chen L, Reed C, Happich M, Nyhuis A, Lenox-Smith A. Health care resource utilisation in primary care prior to and after a diagnosis of Alzheimer’s disease: a retrospective, matched case-control study in the United Kingdom. BMC Geriatr. 2014;14:76.CrossRefPubMedPubMedCentral
4.
go back to reference Beinart N, Weinman J, Wade D, Brady R. Caregiver burden and psychoeducational interventions in Alzheimer’s disease: a review. Dement Geriatr Cogn Disord Extra. 2012;2:638–48.CrossRef Beinart N, Weinman J, Wade D, Brady R. Caregiver burden and psychoeducational interventions in Alzheimer’s disease: a review. Dement Geriatr Cogn Disord Extra. 2012;2:638–48.CrossRef
5.
go back to reference O’Bryant, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 2016 doi 10.1016/j.jalz 2016.09.014 (epub ahead of print). O’Bryant, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 2016 doi 10.​1016/​j.​jalz 2016.09.014 (epub ahead of print).
6.
go back to reference Khan W, Aguilar C, Kiddle SJ, Doyle O, Thambisetty M, Muehlboeck S, et al. A subset of cerebrospinal fluid proteins from a multi-analyte panel associated with brain atrophy, disease classification and prediction in Alzheimer’s disease. PLoS One. 2015;10(8):e0134368.CrossRefPubMedPubMedCentral Khan W, Aguilar C, Kiddle SJ, Doyle O, Thambisetty M, Muehlboeck S, et al. A subset of cerebrospinal fluid proteins from a multi-analyte panel associated with brain atrophy, disease classification and prediction in Alzheimer’s disease. PLoS One. 2015;10(8):e0134368.CrossRefPubMedPubMedCentral
7.
go back to reference Sapey-Triomphe L-A, Heckemann R, Boublay N, Dorey J-M, Henaff M-A, Rouch I, et al. Neuroanatomical correlates of recognizing face expressions in mild stages of Alzheimer’s disease. PLoS One. 2015;10(12):e0143586.CrossRefPubMedPubMedCentral Sapey-Triomphe L-A, Heckemann R, Boublay N, Dorey J-M, Henaff M-A, Rouch I, et al. Neuroanatomical correlates of recognizing face expressions in mild stages of Alzheimer’s disease. PLoS One. 2015;10(12):e0143586.CrossRefPubMedPubMedCentral
8.
go back to reference Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007;78:30–5.CrossRefPubMed Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007;78:30–5.CrossRefPubMed
9.
go back to reference Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226:1441–3.CrossRefPubMed Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226:1441–3.CrossRefPubMed
10.
go back to reference Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease. Arch Neurol. 1998;55:84–90.CrossRefPubMed Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease. Arch Neurol. 1998;55:84–90.CrossRefPubMed
11.
go back to reference Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon RMA. Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia. 2007;45:1823–31.CrossRefPubMed Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon RMA. Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia. 2007;45:1823–31.CrossRefPubMed
12.
go back to reference Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry. 2000;157:1399–405.CrossRefPubMed Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry. 2000;157:1399–405.CrossRefPubMed
13.
go back to reference Nordin S, Murhpy C. Impaired sensory and cognitive olfactory function in questionable Alzheimer’s disease. Neuropsychology. 1996;10:113–9.CrossRef Nordin S, Murhpy C. Impaired sensory and cognitive olfactory function in questionable Alzheimer’s disease. Neuropsychology. 1996;10:113–9.CrossRef
14.
go back to reference Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, et al. Olfactory screening test in mild cognitive impairment. Neurol Sci. 2005;26:156–60.CrossRefPubMed Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, et al. Olfactory screening test in mild cognitive impairment. Neurol Sci. 2005;26:156–60.CrossRefPubMed
15.
go back to reference Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, et al. A 10-item smell identification scale related to risk for Alzheimer’s disease. Ann Neurol. 2005;58:155–60.CrossRefPubMed Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, et al. A 10-item smell identification scale related to risk for Alzheimer’s disease. Ann Neurol. 2005;58:155–60.CrossRefPubMed
16.
go back to reference Duff K, McCaffrey RJ, Solomon GS. The pocket smell test: successfully discrimination probable Alzheimer’s dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci. 2002;14:197–201.CrossRefPubMed Duff K, McCaffrey RJ, Solomon GS. The pocket smell test: successfully discrimination probable Alzheimer’s dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci. 2002;14:197–201.CrossRefPubMed
17.
go back to reference Solomon GS, Petrie WM, Hart JR, Brackin HB Jr. Olfactory dysfunction discriminates Alzheimer’s dementia from major depression. J Neuropsychiatry Clin Neurosci. 1998;10:64–7.CrossRefPubMed Solomon GS, Petrie WM, Hart JR, Brackin HB Jr. Olfactory dysfunction discriminates Alzheimer’s dementia from major depression. J Neuropsychiatry Clin Neurosci. 1998;10:64–7.CrossRefPubMed
18.
go back to reference Nordin S, Brämerson A, Lidén E, Bende M. The Scandinavian odor-identification test: development, reliability and normative data. Acta Otolaryngol. 1998;118:226–34.CrossRefPubMed Nordin S, Brämerson A, Lidén E, Bende M. The Scandinavian odor-identification test: development, reliability and normative data. Acta Otolaryngol. 1998;118:226–34.CrossRefPubMed
19.
go back to reference Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behavior. 1984;32:489–502.CrossRef Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behavior. 1984;32:489–502.CrossRef
20.
go back to reference Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S. “Sniffin’ sticks”: screening of olfactory performance. Rhinology. 1996;34:222–6.PubMed Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S. “Sniffin’ sticks”: screening of olfactory performance. Rhinology. 1996;34:222–6.PubMed
21.
go back to reference Gauthier S. Clinical diagnosis and management of Alzheimer’s disease. 3rd ed. London: Informa Healthcare; 2006.CrossRef Gauthier S. Clinical diagnosis and management of Alzheimer’s disease. 3rd ed. London: Informa Healthcare; 2006.CrossRef
22.
go back to reference Elias M, Beiser A, Wolf PA, Au R, White RF, D’Agostino RB. The preclinical phase of Alzheimer disease. Arch Neurol. 2000;57:808–13.CrossRefPubMed Elias M, Beiser A, Wolf PA, Au R, White RF, D’Agostino RB. The preclinical phase of Alzheimer disease. Arch Neurol. 2000;57:808–13.CrossRefPubMed
23.
go back to reference Wang J, Eslinger PJ, Doty RL, Zimmerman EK, Grunfeld R, Sun X, et al. Olfactory deficit detected by fMRI in early Alzheimer’s disease. Brain Res. 2010;1357:184–94.CrossRefPubMedPubMedCentral Wang J, Eslinger PJ, Doty RL, Zimmerman EK, Grunfeld R, Sun X, et al. Olfactory deficit detected by fMRI in early Alzheimer’s disease. Brain Res. 2010;1357:184–94.CrossRefPubMedPubMedCentral
24.
go back to reference Kjelvik G, Sando SB, Aasly J, Engedal KA, White LR. Use of brief smell identification test for olfactory deficit in a Norwegian population with Alzheimer’s disease. Int J Geriatric Psychiatry. 2007;22:1020–4.CrossRef Kjelvik G, Sando SB, Aasly J, Engedal KA, White LR. Use of brief smell identification test for olfactory deficit in a Norwegian population with Alzheimer’s disease. Int J Geriatric Psychiatry. 2007;22:1020–4.CrossRef
25.
go back to reference Makowska I, Kloszewska I, Grabowska A, Szalkowska I, Rymarczyk K. Olafctory deficit in normal aging and Alzheimer’s disease in the polish elderly population. Arch Clin Neuropsychol. 2011;26:270–9.CrossRefPubMed Makowska I, Kloszewska I, Grabowska A, Szalkowska I, Rymarczyk K. Olafctory deficit in normal aging and Alzheimer’s disease in the polish elderly population. Arch Clin Neuropsychol. 2011;26:270–9.CrossRefPubMed
26.
go back to reference Westervelt HJ, Cavalho J, Duff K. Presentation of Alzheimer’s disease in patients with and without olfactory deficits. Arch Clin Neuropsychol. 2007;22:117–22.CrossRefPubMed Westervelt HJ, Cavalho J, Duff K. Presentation of Alzheimer’s disease in patients with and without olfactory deficits. Arch Clin Neuropsychol. 2007;22:117–22.CrossRefPubMed
27.
go back to reference Damholdt MF, Borghammer P, Larsen L, Ostergaard K. Odor identification deficits identify Parkinson’s disease patients with poor cognitive performance. Mov Disord. 2011;26:2045–50.CrossRefPubMed Damholdt MF, Borghammer P, Larsen L, Ostergaard K. Odor identification deficits identify Parkinson’s disease patients with poor cognitive performance. Mov Disord. 2011;26:2045–50.CrossRefPubMed
Metadata
Title
Olfactory testing in consecutive patients referred with suspected dementia
Authors
Ib Thrane Christensen
Elna-Marie Larsson
Ida E. Holm
Ole B.F. Nielsen
Stig Andersen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2017
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-017-0516-2

Other articles of this Issue 1/2017

BMC Geriatrics 1/2017 Go to the issue